The Dried Bloodspot Collection Card Market is expected to register a CAGR of 4.7% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The report is segmented by Card Type (Ahlstrom 226, Whatman 903, FTA, and Others). The report further presents analysis based on the Application (Infectious Disease Testing, Newborn Screening, Forensics, Therapeutic Drug Monitoring, and Others). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
Purpose of the Report
The report Dried Bloodspot Collection Card Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Dried Bloodspot Collection Card Market Segmentation
Card Type
- Ahlstrom 226
- Whatman 903
- FTA
Application
- Infectious Disease Testing
- Newborn Screening
- Forensics
- Therapeutic Drug Monitoring
Customize This Report To Suit Your Requirement
You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities
Dried Bloodspot Collection Card Market: Strategic Insights

- Get Top Key Market Trends of this report.This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
Dried Bloodspot Collection Card Market Growth Drivers
- Advancements in Diagnostic Testing: Dried bloodspot collection cards (DBS) are increasingly used in point-of-care diagnostics. These cards simplify blood sample collection and storage, providing an affordable, non-invasive alternative for disease detection and monitoring. The growing demand for accurate, rapid diagnostics across various diseases is driving the DBS market, especially in resource-limited settings where traditional lab-based testing may not be feasible.
- Growth in Home Healthcare: The rise of home healthcare services, including telemedicine, has accelerated the adoption of DBS collection cards. These cards enable at-home blood collection, enhancing patient convenience and compliance with healthcare regimens. Additionally, they are used in newborn screening and chronic disease monitoring, especially for diabetes and genetic disorders, thus driving the market’s expansion in personal health monitoring solutions.
- Government Initiatives for Disease Surveillance: Governments across the world are leveraging DBS collection cards for large-scale disease surveillance, particularly in global health emergencies. The use of DBS cards in detecting infectious diseases, including HIV, malaria, and hepatitis, is expanding. These cards help streamline data collection and provide more accessible, cost-effective testing solutions for epidemic control, fueling their growing adoption in public health initiatives.
Dried Bloodspot Collection Card Market Future Trends
- Integration with Digital Health Platforms: DBS collection cards are increasingly being integrated with digital health technologies, such as mobile apps and cloud-based platforms, to enable remote monitoring and diagnosis. This trend is driving the development of smart DBS cards that can transmit results directly to healthcare providers, enhancing efficiency, accuracy, and convenience for both patients and clinicians in managing chronic conditions and infectious diseases.
- Miniaturization of DBS Cards: The miniaturization of DBS cards is another growing trend. With more compact and easy-to-use designs, these collection cards are becoming even more practical for patients and healthcare workers. Small, portable devices enable more convenient and frequent sample collection, particularly for at-home testing and fieldwork in remote or underserved regions, increasing accessibility and reducing barriers to healthcare.
- Rising Popularity in Personalized Medicine: The demand for personalized medicine has led to an increase in the use of DBS collection cards for genetic testing and disease prevention. Their ability to efficiently collect DNA and biomarker samples in a non-invasive manner makes them ideal for personalized diagnostic applications, including pharmacogenomic testing and tailored treatment plans for chronic diseases, which are becoming more prevalent in the healthcare industry.
Dried Bloodspot Collection Card Market Opportunities
- Expanding Applications in Disease Monitoring: DBS cards present a significant opportunity for expanding applications in disease monitoring, particularly for chronic diseases like diabetes, cardiovascular conditions, and genetic disorders. The cards provide a cost-effective way to track biomarkers and make regular health assessments more accessible, creating opportunities for widespread adoption in routine healthcare settings and clinical trials.
- Emerging Markets Adoption: Emerging markets with limited access to traditional healthcare infrastructure offer growth opportunities for the DBS collection card market. Their low-cost, portable, and easy-to-use nature makes DBS cards ideal for diagnostic applications in these regions. The growing focus on improving healthcare access in underserved areas provides a clear path for expanding market reach in these regions.
- Development of New Testing Methods: New testing methods and innovations in biomarkers are creating opportunities for DBS collection cards in new areas such as cancer diagnostics, infectious disease detection, and prenatal testing. As research in these fields advances, the potential for DBS cards to be used in more precise and diverse diagnostic applications is growing, leading to further market expansion.
Dried Bloodspot Collection Card Market Regional Insights
The regional trends and factors influencing the Dried Bloodspot Collection Card Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Dried Bloodspot Collection Card Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

- Get the Regional Specific Data for Dried Bloodspot Collection Card Market
Dried Bloodspot Collection Card Market Report Scope
Report Attribute | Details |
---|---|
Market size in 2024 | US$ XX million |
Market Size by 2031 | US$ XX Million |
Global CAGR (2025 - 2031) | 4.7% |
Historical Data | 2021-2023 |
Forecast period | 2025-2031 |
Segments Covered |
By Card Type
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
Dried Bloodspot Collection Card Market Players Density: Understanding Its Impact on Business Dynamics
The Dried Bloodspot Collection Card Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Dried Bloodspot Collection Card Market are:
- Thermo Fisher Scientific
- PerkinElmer
- F. Hoffmann-La Roche
- Abbott Laboratories
- Bio-Rad Laboratories
- Neogen Corporation
Disclaimer: The companies listed above are not ranked in any particular order.

- Get the Dried Bloodspot Collection Card Market top key players overview
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Dried Bloodspot Collection Card Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Dried Bloodspot Collection Card Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset


- Oxy-fuel Combustion Technology Market
- Social Employee Recognition System Market
- Playout Solutions Market
- Hydrolyzed Collagen Market
- Enzymatic DNA Synthesis Market
- EMC Testing Market
- Excimer & Femtosecond Ophthalmic Lasers Market
- Intradermal Injection Market
- Joint Pain Injection Market
- GMP Cytokines Market

Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
This text is related
to segments covered.

Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
This text is related
to country scope.
Frequently Asked Questions
Advances in diagnostic testing, growth in home healthcare, and government disease surveillance initiatives are the primary drivers of the market.
Digital health platforms enable real-time data transmission and remote monitoring, improving patient convenience and increasing DBS card adoption in diagnostics.
Regulatory challenges, technological integration issues, and the need for standardized testing methods pose significant hurdles for the market.
Emerging economies offer substantial growth potential due to the increasing need for affordable, accessible healthcare solutions.
Healthcare diagnostics, newborn screening, pharmaceutical companies, and academic research are the main sectors adopting DBS collection cards.
DBS cards allow non-invasive sample collection for genetic testing and pharmacogenomics, supporting personalized treatment strategies.
Trends and growth analysis reports related to Life Sciences : READ MORE..
- Thermo Fisher Scientific
- PerkinElmer
- F. Hoffmann-La Roche
- Abbott Laboratories
- Bio-Rad Laboratories
- Neogen Corporation
- GFE GmbH
- Enzo Biochem
- Scisco
- Sanguine BioSciences